Clinical trials in pediatrics often follow a phased approach, starting with Phase I trials to assess safety and pharmacokinetics, followed by Phase II and III trials to evaluate efficacy and further safety. Special considerations are given to trial design, including the use of age-appropriate endpoints and minimizing the number of invasive procedures.
